The University of Michigan at Ann Arbor is one of the most richly funded markets in the country for biotechnology vendors and lab suppliers, as recent NIH and NSF research funding statistics show. In 2012, the NIH gave the University of Michigan $456.3 million in research funding. The money has been awarded to various departments for research projects including:
Biotechnology vendors and lab suppliers in Illinois will find a well-funded market of science researchers at the University of Illinois Urbana-Champaign, according to recent NIH and NSF funding statistics. In 2012, the NIH awarded the university $69.7 million in research funding. Of the different bio departments at the University of Illinois Urbana-Champaign, the money was distributed as follows:
The Parkinson's Disease Biomarkers Program (PDBP) is a recently-formed NIH initiative to advance research into biomarkers for the disease in order to better understand its progress and develop treatments. Some funded projects will focus on statistical analysis tools and data sharing among researchers. Others will examine early clinical manifestations of PD in patients. Still more will involve lab studies, including identification of genetic biomarkers as well as antibodies in the blood and changes in body chemistry. All projects "must inform the etiology, pathogenesis or treatment of PD," according to grant program guidelines. Research supported by the PDBP is being carried out at the 11 Morris K. Udall Centers of Excellence in Parkinson's Disease Research (logo right), directed by the National Institute of Neurological Disorders and Stroke (NINDS) within the NIH.
Tags: 2014, 2013, Pennsylvania, Northeast, University of Pennsylvania, UPenn, Thomas Jefferson University, Parkinson's Disease Research, Biomarkers, Philadelphia, BioResearch Product Faire Event, Funding, Genomics, Neurology, NIH, Northeast Region, ThomJeff
The Department of Neuroscience at New York's Mount Sinai School of Medicine comprises 25 research laboratories with total NIH funding for 2012 of $19.3M. Most labs are on the 9th Floor of the Icahn Medical Institute building on Madison Avenue. Neuroscience faculty may also receive support and engage in collaborative research through MSSM's Friedman Brain Institute, which coordinates brain and spinal cord research from departments and clinics across the medical school campus. In fact, the largest recipient of 2012 NIH funding at MSSM Neuroscience is Brain institute Director Eric J. Nestler, MD, PhD.
It's an honor to receive a postdoctoral fellowship to continue your professional training in an established lab just after getting your PhD; it's even more prestigious to to win a postdoc fellowship to start your own lab research program. Dr. Brad Rosenberg finished the clinical portion of his M.D.-PhD program last year at Weill Cornell Medical Center, having earned his PhD from Rockefeller University through the Tri-Institutional Program two years earlier. This year he is conducting his own research at Rockefeller using advanced high-throughput sequencing techniques to analyze lymphocytes in the immune system.
A University of Illinois, Chicago discovery may hold the solution to successfully treating recovering stroke victims. After surviving a stroke, these outpatients can go through years of physical therapy in an attempt to regain one of the most important senses we as people have: our sense of balance. Without it, walking and moving become constant challenges, and the fear of falling becomes an everyday struggle. However, Alexander Aruin, a physical therapy professor at UI Chicago, has made a discovery that could change the lives of these stroke survivors for the better.
"High-risk, high-reward" life science research funding isn't something we hear about very often in these days of fiscal belt-tightening, especially coming from the private sector. Fortunately the NIH is still committed to supporting exceptional life science labs that take the road less travelled, with the Director's Transformative Research Awards and the Director's New Innovator Awards, because the potential payoff justifies the gamble taken. The NIH has standard criteria by which they evaluate grant proposals. Realizing that those criteria would enevitably leave out some of the most daring and ground-breaking research, they came up with the High Risk awards. 2012 Director's Awards from the NIH Common Fund (totalling some $155M) have gone to 81 investigators, and 5 of them are faculty members and heads of laboratories at Rockefeller University.
Tags: Rockefeller University, Northeast, RNA research, New York, 2012, biology research, BioResearch Product Faire Event, Funding, NY, NIH, New York City, new research grants, Rockefeller, early career funding
The University of Washington, Seattle recently received a $65 million grant from the NIH to help improve and streamline the UW Institute of Translational Health Sciences (ITHS) research program. This is the second grant of this type awarded to UW and will fund the program over a five year period.
The Clinical & Translational Science Center (CTSC) headquartered at Manhattan's Weill Cornell Medical College has just received a $49.6M renewal of its 5-year grant by the NIH's National Center for Advancing Translational Sciences (NCATS) in order to continue its work. Launched seven years ago, the the CTSC set out to realize the successful integration of inter-institutional resources among neighbors on York Avenue and the immediate area. The resulting cluster of New York's East Side institutions forms a unique and cohesive biomedical complex collectively dedicated to accelerating the clinical application of basic science discoveries.
Tags: Rockefeller University, Northeast, Translational Research, New research facilities, new science wet labs, New York, Columbia University, 2012, Weill Cornell, Columbia, MSSM, RockU, BioResearch Product Faire Event, Funding, NY, NIH, Stoneybrook, SunySB, NYC campus competition, Mt Sinai School of Medicine
The Washington-based Pacific Northwest Prostate Cancer SPORE (Specialized Programs of Research Excellence) is a cutting-edge life science consortium which includes several research centers throughout Washington State and British Columbia. The consortium focuses on the genetic mechanisms of prostate cancer to better develop effective treatments for the disease.
Tags: Fred Hutchinson Cancer Research Center, UW, University of Washington, WA research, 2012, Washington Life Science, washington life science consortium, BioResearch Product Faire Event, Front Line event, NIH, Seattle, research grant